Background The clinical efficacy of mechanical thrombectomy has been unequivocally
demonstrated in multiple randomized clinical trials. However, these studies were performed …

More than 30 years after initial reports demonstrated the feasibility of intra-arterial or
endovascular therapies for the treatment of acute ischemic stroke, big data have finally …

The ESCAPE trial demonstrated strong morbidity benefit and mortality reduction for
endovascular stroke treatment. Following the release of the main results, the ESCAPE trial …

Background Evidence regarding whether imaging can be used effectively to select patients
for endovascular thrombectomy (EVT) is scarce. We aimed to investigate the association …

Introduction: The benefit of endovascular therapy (EVT) among stroke patients with large
ischemic core (ASPECTS 0–5) in the extended time window outside of trial settings remains …

Background Whether brain imaging can identify patients who are most likely to benefit from
therapies for acute ischemic stroke and whether endovascular thrombectomy improves …

Ischemic stroke is caused by a thrombus that blocks an intracranial artery. Brain tissue
beyond the blocked artery survives for a variable period of time because of blood and …

Background and Purpose: The clinical efficacy of mechanical thrombectomy (MT) has been
unequivocally demonstrated in multiple randomized clinical trials (RCTs). However, these …

Stroke is the second leading cause of mortality and the third leading cause of disability-
adjusted life-years worldwide. For each minute of an ischemic stroke, an estimated 1.9 …

Background and purpose Long-term follow-up of large trials have confirmed the superiority
of endovascular thrombectomy (ET) for treating acute ischemic stroke (AIS). However, it is …